Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

November 30, 2025

Conditions
Diabetes MellitusType 1 DiabetesType 2 Diabetes
Interventions
DEVICE

RIGHTEST Continuous Glucose Monitoring System

RIGHTEST Continuous Glucose Monitoring System

Trial Locations (13)

11413

Scott Research,Inc, Laurelton

28401

PMG Research of Wilmington, LLC, Wilmington

29607

The Research Center of the Upstate, Greenville

30274

Infinite Clinical Trials, Morrow

30318

Atlanta Diabetes Associates, Atlanta

35951

Lakeview Clinical Research, Guntersville

40213

L-MARC Research Center, Louisville

42303

Research Integrity, LLC., Owensboro

85741

Novak Clinical Research, Tucson

91303

Hope Clinical Research LLC, Canoga Park

92029

AMCR Institute, Escondido

94598

Diablo Clinical Research, Inc., Walnut Creek

97239

Oregon Health, Portland

Sponsors
All Listed Sponsors
lead

Bionime Corporation

INDUSTRY